Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2023 No.24

Total 18 articles

Overview of accelerated assessment and approval policies for cell and gene therapy products in the United States and Europe and its implications for ChinaWANG Jing, LU Shuang

2441-2446

A brief analysis of the focus of production capacity research of autologous CAR-T therapeutic productsWANG Xue, MA Yan-song, WEI Wei, HE Wu

2447-2451

Considerations on pharmaceutical quality assessment and control of lipid nanoparticles of prophylactic mRNA vaccinesYANG Dan, ZHAO Xin, LI Xiao-jing, LI Min

2452-2456

Several special considerations on the registration of post-approval changes for vaccines based on lifecycle managementJIN Su, GUO Sheng-nan, QIU Xiao, GUO Shu-yang, YIN Xiao, XIANG Jin-zhong, LI Min

2457-2462

Considerations of pharmaceutical review of therapeutic recombinant protein drugs for subcutaneous injectionSAI Wen-bo, XU Long-chang

2463-2466

Quality control and evaluation concerns of recombinant glycoprotein hormones:"macro"and"micro"heterogeneity of glycosylation modificationsLI Yi-jun, HU Ying-ying, WEI Wei

2467-2476

Discussion on similarity assessment of denosumab biosimilarsKAN Hong-jin, WEI Wei

2477-2482

Research progress and regulatory perspectives in neoantigen immunotherapyLI Qian, DAI Yi-fei, WEI Wei

2483-2488

Risk management and technical considerations on donor screening for cellular therapy productsLIU Dan, JIA Dong-chen, CUI Jing, WEI Wei

2489-2494

Research progress in SARS-CoV-2 neutralizing antibody products and pharmaceutical assessmentJIA Dong-chen, WU Zhou-yi, YU Peng-li

2495-2500